<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03462758</url>
  </required_header>
  <id_info>
    <org_study_id>172101</org_study_id>
    <nct_id>NCT03462758</nct_id>
  </id_info>
  <brief_title>Early vs. Interval Postpartum IUD Insertion</brief_title>
  <acronym>EPPIUD</acronym>
  <official_title>Early vs. Interval Postpartum IUD Insertion: A Multi-site Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Naval Medical Center, San Diego</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intrauterine devices (IUDs) are historically placed at a six-week postpartum visit for women
      who desire intrauterine contraception after delivery. A two-week postpartum visit could be a
      convenient time for women to receive contraception, including IUDs. Offering women IUDs at
      two-weeks postpartum may decrease the risk of undesired pregnancy and rapid repeat pregnancy.
      This study will compare IUD insertion at two different times after delivery: two-weeks and
      six-weeks postpartum. This will allow researchers to assess whether the timing of IUD
      placement affects whether an IUD is expelled, or pushed out of it's ideal location.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine the proportion of IUDs inserted in the Early
      Postpartum (EPP) period that are expelled at 6 months postpartum. This prospective,
      multi-site randomized trial will enroll approximately 424 women at three large academic
      hospitals in the United States.

      Women will be recruited who are interested in receiving a levonorgestrel-IUD or a copper-IUD
      after delivery. Postpartum women who desire an IUD will be randomized to EPP IUD insertion
      (between 14-28 days PP) or interval postpartum IUD insertion (42-56 days PP) and the
      proportion of IUDs expelled will be compared between groups at 6 months postpartum. All women
      will be seen in clinic at 6-8 weeks and 6 months postpartum. Women randomized to EPP IUD
      placement will be seen at 2-3 weeks postpartum.

      Provider perspectives of EPP IUD placement will also be evaluated, as will whether these
      attitudes change after 6 to 9 months of providing early postpartum IUDs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IUD utilization</measure>
    <time_frame>6 months postpartum</time_frame>
    <description>IUD utilization will be defined as intrauterine use of an IUD at 6 months postpartum. A speculum exam and transvaginal ultrasound will be performed on all patients at 6 months postpartum to confirm IUD use</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IUD expulsion (complete)</measure>
    <time_frame>6 months postpartum</time_frame>
    <description>Complete IUD expulsion will be defined as an IUD which no longer in the uterus on transvaginal ultrasound and not found in the abdomen or pelvis on x-ray. A speculum exam and transvaginal ultrasound will be performed on all patients at 6 months postpartum. If expulsion has occurred, the participant will have an abdominal x-ray to confirm expulsion (and rule out perforation).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IUD expulsion (partial)</measure>
    <time_frame>6 months</time_frame>
    <description>Partial IUD expulsions will be diagnosed in any participant found to have an IUD in which part of the body of the IUD is noted to be coming through the external cervical os on speculum exam.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic infection</measure>
    <time_frame>6 months</time_frame>
    <description>Pelvic infection requiring antibiotics will be ascertained by patient report and/or medical record review.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>6 months</time_frame>
    <description>A questionnaire will be administered to determine the participant's satisfaction with the IUD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Provider perceptions of early postpartum IUD placement</measure>
    <time_frame>6 months</time_frame>
    <description>Provider perceptions of early postpartum IUD placement will be ascertained by qualitative interviews with providers and by surveys of providers before and after experience with early postpartum IUD placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IUD perforation</measure>
    <time_frame>6 months</time_frame>
    <description>UD perforations through the uterus will be diagnosed when an IUD visible is not visible on transvaginal ultrasound of the uterus but is visible on x-ray of the abdomen or pelvis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">424</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>IUD placed 6-8 weeks postpartum (standard of care, interval placement)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IUD placed 2-4 weeks postpartum (early postpartum placement, EPP)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IUD</intervention_name>
    <description>Postpartum IUD placement</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Intervention Group</arm_group_label>
    <other_name>Mirena, Kyleena, Skyla, Liletta, ParaGard</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gave birth less than or equal to 10 days ago

          -  Desires to use an IUD for Contraception (either copper or levonorgestrel)

          -  Willing and able to sign an informed consent

          -  Willing to comply with the study protocol

          -  Age greater than or equal to 18 years

          -  English or Spanish speaking

        Exclusion Criteria:

          -  Uterine anomaly or leiomyomata which would not allow placement of an IUD

          -  Desire for repeat pregnancy in less than 6 months

          -  Evidence of intrauterine infection (chorioamnionitis or postpartum endometritis)
             treated with antibiotics

          -  Ruptured uterus at the time of delivery

          -  Received a postpartum tubal ligation or immediate postpartum IUD or implant at
             delivery

          -  Incarcerated women or women with significant cognitive impairment

          -  4th degree perineal laceration sustained at delivery

          -  Any medical contraindication to IUD per the US CDC Medical Eligibility Criteria

          -  Suspicion for new pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Averbach, MD, MAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marisa Hildebrand, MPH</last_name>
    <phone>8583294464</phone>
    <email>familyplanningresearch@ucsd.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarah Averbach, MD, MAS</last_name>
    <phone>8582491205</phone>
    <email>saverbach@ucsd.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisa Hildebrand, MPH</last_name>
      <email>familyplanningresearch@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Sarah Averbach, MD, MAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sharon Stortz, MD</last_name>
      <phone>619-807-6551</phone>
      <email>Sharon.k.stortz@mil.mail.mil</email>
    </contact>
    <investigator>
      <last_name>Antoinette Marengo-Barbick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sadia Haider, MD, MPH</last_name>
      <phone>773-834-4063</phone>
      <email>shaider2@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Sadia Haider, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lisa Hofler, MD, MPH, MBA</last_name>
      <phone>505-205-4118</phone>
      <email>HSC-FamilyPlanningResearch@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Lisa Hofler, MD, MPH, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Regan Riley, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Sarah Averbach, MD MAS</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Mirena</keyword>
  <keyword>ParaGard</keyword>
  <keyword>Skyla</keyword>
  <keyword>Liletta</keyword>
  <keyword>Kyleena</keyword>
  <keyword>Intrauterine Device</keyword>
  <keyword>Intrauterine System</keyword>
  <keyword>Postpartum</keyword>
  <keyword>Expulsion</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

